Market cap
₹3,772 Cr
Recently Viewed
Clear AllNSE: ADVENZYMES | BSE: 540025
₹337.75
₹-4.25
(-1.24%)
As on 29-Apr-2026IST
Market cap
₹3,772 Cr
Revenue (TTM)
₹710 Cr
P/E Ratio
24.8
P/B Ratio
2.5
Div. Yield
1.5 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹152 Cr
ROE
9.8 %
ROCE
13.8 %
Industry P/E
36.06
EV/EBITDA
15
Debt to Equity
0
Book Value
₹136.5
EPS
₹12.9
Face value
2
Shares outstanding
111,926,800
CFO
₹1,295.68 Cr
EBITDA
₹1,831.76 Cr
Net Profit
₹1,162.08 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Advanced Enzyme
| 11.7 | 27.0 | 20.5 | 17.2 | 9.4 | -3.6 | -- |
|
BSE Commodities
| 7.4 | 14.3 | 3.5 | 16.8 | 17.9 | 12.9 | 16.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Advanced Enzyme
| -13.8 | -6.8 | 33.7 | -13.9 | -3.1 | 103.5 | -5.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Advanced Enzyme
|
337.8 | 3,772.5 | 709.6 | 155.1 | 24.2 | 9.9 | 24.8 | 2.5 |
| 502.4 | 18,211.3 | 8,045.0 | 378.0 | 7.8 | 6.6 | 48.2 | 3.1 | |
| 1,168.1 | 15,453.9 | 1,088.6 | 215.8 | 27.4 | 9.8 | 71.6 | 6.4 | |
| 1,294.7 | 14,748.5 | 2,229.8 | 229.1 | 18.1 | 5.7 | 85.7 | 4.5 | |
| 1,724.1 | 23,510.1 | 7,946.4 | 533.3 | 8.9 | 9.9 | 44.1 | 4.2 | |
| 4,721.6 | 14,503.1 | 2,347.3 | 398.8 | 17.9 | 16.4 | 36.6 | 5.7 | |
| 3,813.3 | 8,873.7 | 2,071.4 | 307.8 | 17.4 | 12.6 | 28.8 | 3.5 | |
| 702.8 | 11,180.7 | 4,260.9 | 265.7 | 9.0 | 9.2 | 42.1 | 3.6 | |
| 3,317.6 | 12,967.1 | 2,455.7 | 286.6 | 18.6 | 25.6 | 43.2 | 9.9 | |
| 1,314.6 | 13,642.4 | 2,271.4 | 442.9 | 24.7 | 15.5 | 30.8 | 4.5 |
No Review & Analysis are available.
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers... enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India. Read more
Incorporated
1989
Chairman
Vasant Rathi
Managing Director
--
Headquarters
Thane, Maharashtra
Website
Looking for more details about Advanced Enzyme Technologies Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Advanced Enzyme Technologies Ltd is ₹337.75 (NSE) and ₹337.05 (BSE) as of 29-Apr-2026 IST. Advanced Enzyme Technologies Ltd has given a return of 9.37% in the last 3 years.
The P/E ratio of Advanced Enzyme Technologies Ltd is 24.78 times as on 29-Apr-2026, a 31 discount to its peers’ median range of 36.06 times.
The P/B ratio of Advanced Enzyme Technologies Ltd is 2.47 times as on 29-Apr-2026, a 0 discount to its peers’ median range of 2.48 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
23.80
|
2.20
|
|
2024
|
29.15
|
2.94
|
|
2023
|
24.52
|
2.10
|
|
2022
|
26.37
|
2.90
|
|
2021
|
26.40
|
3.98
|
The 52-week high and low of Advanced Enzyme Technologies Ltd are Rs 366.25 and Rs 251.95 as of 29-Apr-2026.
Advanced Enzyme Technologies Ltd has a market capitalisation of ₹ 3,772 Cr as on 29-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Advanced Enzyme Technologies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.